Remove Immunization Remove Medical Schools Remove Workshop
article thumbnail

TIGIT Therapies 2021

pharmaphorum

Plus 2 add on workshops: • Elucidating the anti-tumor immunity of other immune checkpoint inhibitors in oncology. David Hafler, Yale School of Medicine. Vijay Kuchroo, Harvard Medical School and Brigam & Women’s Hospital. Walter Fiedler and Franziska Brauneck, University Medical Center Hamburg-Eppendorf.

article thumbnail

Non-Small Cell Lung Cancer Drug Development Summit

pharmaphorum

Harness the power of the immune system to treat NSCLC by delving into the current best, novel targets and combination strategies to improve patent outlook with Merck & Co, Immutep, BerGenBio and Bristol-Myers Squibb. View the event guide now for more details!